Dr. Fernando Albarracin from the Technology Innovation Institute has presented a novel microwave applicator design for hyperthermia, potentially useful in cancer treatment. The design combines two flat dielectric graded-index (GRIN) lenses to localize electromagnetic energy within a specific spot in the tissue. This system offers a suitable alternative to conventional antenna-based applicators by considering the interface between free space and human tissue. Why it matters: This research introduces a new approach to hyperthermia treatment that could improve the precision and effectiveness of cancer therapy in the region.
Researchers from KAUST and the University of Padova studied how hyperoxia, or excessive oxygen supply, extends heat tolerance in marine ectotherms. The study, published in Science Advances, examined the role of photosynthetic organisms like seagrasses in producing oxygen in aquatic habitats. They found that increased oxygen availability helps coastal marine animals like crabs, sea cucumbers, and shellfish increase their resilience to rising temperatures. Why it matters: Understanding the interplay between oxygen levels and temperature tolerance can inform strategies for preserving marine ecosystems in the face of global warming.
KAUST Research Scientist Dr. Ram Karan received a Young Scientist Award at the 15th International Congress on Thermophiles in Japan for his work on extremozymes from Red Sea brine pools. His research focuses on identifying, purifying, and bioengineering microbial proteins from these pools. He utilizes single-amplified genomes (SAGs) to produce extremozyme proteins without needing to grow cells in the lab. Why it matters: This award recognizes KAUST's innovative research into extremophiles, which have the potential to develop novel, sustainable biotechnical processes for industrial applications.
IBM and MBZUAI have partnered to create an AI Center of Excellence, with the goal of driving sustainability in the region. The center will use AI to monitor, model, and visualize climate change, providing decision-makers with data to address issues like the urban heat island effect. Dr. Fahad Khan, Dr. Salman Khan, and Dr. Levente Klein from MBZUAI are leading the research. Why it matters: This collaboration highlights the UAE's commitment to using AI to tackle critical climate challenges and supports the upcoming COP28 in Dubai.
KAUST researchers led by Dr. Niveen Khashab have developed thermosensitive liposomes for controlled drug release, particularly in cancer therapies. The liposomes are designed to release drugs only when they reach heated tumor tissue, minimizing systemic side effects. Cholesterol moieties are used as anchors to create a "nail" or "comb" effect, enabling temperature-triggered drug release inside cells. Why it matters: This targeted drug delivery system could significantly improve the efficacy and reduce the toxicity of cancer treatments.
MBZUAI is developing AI-powered applications to help reduce malaria's impact in Indonesia, supported by Sheikh Mohamed bin Zayed Al Nahyan's Reaching the Last Mile initiative. The applications use sensory data fusion to create "digital twins" for precise weather forecasting and real-time environmental representation. AI and clustering analysis identify recurring features contributing to malaria outbreaks, enabling preventative measures and early treatment. Why it matters: This project demonstrates AI's potential in combating climate-sensitive diseases and improving public health in vulnerable regions.
This paper examines the relationship between COVID-19 spread and weather patterns across 89 cities in Saudi Arabia using machine learning. The study uses daily COVID-19 case reports from the Saudi Ministry of Health and historical weather data. The results indicate that temperature and wind speed have the strongest correlation with the spread of COVID-19, with a random forest model achieving the best performance.
KAUST researchers developed a statistical approach to improve the identification of cancer-related protein mutations by reducing false positives. The method uses Bayesian statistics to analyze protein domain data from tumor samples, accounting for potential errors due to limited data. The team tested their method on prostate cancer data, successfully identifying a known cancer-linked mutation in the DNA binding protein cd00083. Why it matters: This enhances the reliability of cancer research at the molecular level, potentially accelerating the discovery of new therapeutic targets.